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by
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A HISTORY OF QUALITY OF LIFE MEASUREMENTS. Jordan M. Prutkin and
Alvan R. Feinstein. (Sponsored by Harlan M. Krumholz). Department of Internal
Medicine, Yale University, School of Medicine, New Haven, CT.
Purpose: To review the origins and early development of “quality of life”
measurements in the medical literature.
Methods: A comprehensive literature review of Medline from 1966-1986
examining articles with “quality of life” as a subject heading. Studies were
included if they were the original article describing a scale’s development or
used scales developed in the social science literature.
Results: The measurements have been derived from two separate sources: a
transfer and expansion of medical appraisals for “health status”, and an
application of sociometric and psychometric methods for populational
assessment of happiness, well-being, and other “affects”. Neither source of
measurements used the basic principle that a person’s “quality of life” is a state
of mind, not a state of health, and that a suitable personal expression should
allow the opportunity to cite distinctive individual feelings. In addition, the
existing approaches are often unsatisfactory for denoting changes.
Conclusions: Since “quality of life” of individual patients was not directly
sought with the two original sources, its appraisal may be improved with an old
clinical method of asking patients what they believe.
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Introduction
Although “quality of life” is now frequently discussed and measured in
the medical literature, the measurements seem to be done with diverse
approaches, methods, and components. Among the components used in various
studies are the following: general health status, functional capacity, emotional
function, level of well-being, life satisfaction, happiness, intellectual level, pain,
nausea and vomiting, level of symptoms, fatigue, sexual functioning, social
activity, memory level, financial status, and job status. Despite claims that the
methods used to measure quality of life were “valid”, many studies use only one
or two of these components to represent “quality of life,” even though many
investigators believe this concept is usually defined more broadly [1].
These problems may arise because researchers sometimes create new
instruments without a thorough search of previous literature. A more likely
explanation, however, is that quality of life has not been a suitably defined
concept. Quality of life appraisal may have originated in a manner that has
produced the unsatisfactory framework for current measurements.
Although the current problems in quality-of-life measurement have been
recently reviewed[2-9], the history of quality-of-life measurements has not been
traced to show their entrance and early evolution in medicine. By knowing how
the measurements developed, it is possible to provide an explanation for the
current dissatisfaction and debate surrounding their use. This review traces the
development of the early functional status scales and sociological surveys that
were later used in the medical literature to connote quality of life.
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Statement of Purpose
In this thesis, the origin and earliest uses of “quality of life” in the medical
literature are examined. The current indexes seem to have arisen from two
different sources: a direct transfer of indexes developed medically for measuring
“health status”, and an appropriation of non-medical methods used to identify
social and psychologic conditions. The disparate approaches and concepts of
these two sources may contribute to the current confusion of the definition and
measurement of “quality of life” [10-17]. This review concludes by suggesting a
proposal for the implementation of a single global rating of quality-of-life.
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Methods
A Medline searches was completed using the subject heading “quality of
life,” including only English language articles from 1966-1986. In addition,
“quality of life” and “quality of survival” were examined as textwords from
1966-1986. The year 1986 was chosen as the end time-point because more recent
reviews have documented developments in quality of life measurement after this
time. This initial search yielded about 900 references.
In another pursuit, the term “quality of life” was searched as a keyword in
Yale University’s ORBIS database (the online library catalogue of books dating
from 1977). Lastly, “quality of life” was searched in the card catalogue for books
before 1977. Approximately 100 titles were found using this method.
Titles and abstracts were then screened to determine whether established
or new instruments had been used to assess quality of life. By using the reference
lists and bibliographies, the original studies which detailed the development and
validation of the scales were discovered. Studies were included if they were the
original article describing a scale’s development or if they used scales developed
in the social science literature.
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Results
The simultaneous development of functional status measures in the
medical literature and social indicators in the social science literature were later
used either solely or in combination with other measures in the rating of quality
of life. The description that follows first traces the development of functional
status measures, then describes the concurrent events in the social sciences that
led to the development of subjective measures of well-being, and lastly shows
how these two streams came together in the medical literature to produce the
current quality-of-life measures.

Development of Functional Status Indexes
Appraisal of Functional Status
The earliest attempts to examine non-biologic aspects of patient’s daily
behavior seem to have been objective measurements of functional health status,
defined as the ability to perform routine self-care and complete basic physical
activities, and level of independent living.
The first functional classification scale for adults[18], published in 1937,
was a joint project of New York’s City Research Bureau of the Welfare Council,
City Department of Public Welfare, and State Department of Social Welfare.
Intended to examine the medical needs of elderly people receiving public
assistance in New York City, the study analyzed differences “between those who
are… incapacitated in various ways for normal living and those whose capacity
for normal living is not seriously impaired.” Patients were classified in four
categories: I, no obvious disability; II, up and able to get about; III, homebound;
and IV, bedridden.
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Two years later, in 1939, the New York Heart Association Classification[19]
was published by a committee evaluating the functional capacity of patients with
heart disease. They were categorized in four classes: I, no restrictions on activity;
II, slight limitations; III, marked limitation; and IV, inability to complete any
physical activity without discomfort, and possibly angina at rest. Similar
categories of limitation were used in the late 1940’s by the Visick Scale for postgastrectomy patients[20] and by the American Rheumatism Association
Classification[21].
In 1947, Zeman[22] published a classification that contained categories for
both functional capacity and occupational skill in patients over the age of 60
years, living in an old age home. Functional capacity was listed in five
categories: Class A, unlimited and unsupervised activity; Class B, moderate
activity with minimal assistance; Class C, limited capabilities and practically
homebound; Class D, confined to bed; and Class E, blind or severely visually
impaired. Level of skill was cited in three categories: 1, specialized; 2, ordinary;
and 3, unskilled or handicapped. Thus, an active carpenter or trained cook
would be classified A1, whereas a partially restricted person with no specific
skills would be B3.
In 1948, David Karnofsky, evaluating the performance status of cancer
patients, published a single numerical scale[23] that gave scores from 0 to 100 for
a combination of three factors: the ability to carry out normal activities, including
work; the need for custodial care; and the need for medical care. An improved
rating on the Karnofsky scale was one of the attributes used to determine the
clinical effectiveness of nitrogen mustards in palliative treatment[24].
In 1957, Moskowitz and McCann[25] published the PULSES profile. It
was derived from the PULHEMS Profile developed by the Canadian army[26]
and the later PULHES Profile used by the US Army[27] to examine the functional
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levels of new soldiers in World War II. PULSES—an acronym for Physical
condition, Upper extremities, Lower extremities, Sensory components, Excretory
function, and mental and emotional Status—was a tandem profile index in which
each of the 6 domains received a score of 1-4. The PULSES profile was probably
the first functional status index to include mental and emotional status.
In 1958 and 1959, S. Katz and colleagues at a facility for chronic care in
Cleveland reported the Index of Independence of Activities of Daily Living[28,29].
Originally used to evaluate functional deterioration in patients with hip
fractures, the items in the index included such activities as employment,
participation in social groups, preparation of own meals, bathing, transferring to
bed, and walking up stairs. The index was subsequently[30] applied to other
patients with chronic diseases such as stroke, multiple sclerosis, and arthritis.
The authors initially chose the component items from previous experience plus a
review of the literature, but the items were later[29] reduced to six: bathing,
dressing, going to the toilet, transferring into and out of bed, continence, and
feeding. The ratings of A-G depended on the number of activities patients could
not complete.
The Barthel Index[31], from two chronic disease hospitals in Maryland, was
first published in 1958. Originally developed to assess rehabilitation potential in
patients with musculoskeletal or neuromuscular disorders, the index rated
patients’ independence according to the amount of assistance required in 10
activities. Different weightings were used for the original ten items, which
included feeding, transferring from wheelchair to bed, coming to a sitting
position, personal toilet (brushing teeth, shaving, washing face), going to the
toilet, walking on level surface, managing stairs, dressing, bowel continence, and
urinary continence. A patient who required no help received full credit for the
activity while lower scores were given for increasing amounts of assistance. In
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this index, continence was weighted heavily (both for transferring to the toilet
and for maintaining urinary and bowel continence) because of its social
consequences and the amount of time required to attend to an incontinent
patient. The Barthel index, which could be used repeatedly to assess patients’
changes, was later[32] amended to add “bathing” and remove “coming to a
sitting position.”
Chronologically, the next pertinent index appeared in 1960 when Zubrod
and colleagues from the Eastern Cooperative Cancer Chemotherapy Group
reported a particularly simple measurement of patient performance according to
the amount of time spent in bed[33]. Scores ranged from zero for normal activity
to four for bed restriction.
Lawton and Brody’s Instrumental Activities of Daily Living Scale[34], in
1969, appraised patients' abilities in such daily tasks as shopping, food
preparation, housekeeping, laundry, use of telephone, mode of transportation,
responsibility for medications, and ability to handle finances. The scale was
devised with the practical goals of making assessments, planning treatment,
assisting casework, aiding the teaching/training process, and helping determine
the heed for facilities and services.
All of these early functional status indexes were developed under medical
auspices; and many of the indexes are either still used today or became a basis
for later alterations[17]. In a 1969 review, Bruett and Overs[35] noted many
unpublished indexes as well as 12 ADL scales dating from before 1969; and we
have also found 24 more[36-59].
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Development of Social Science Indexes
Government Activities
In 1948, after the World Health Organization[60] defined health as “not
only the absence of infirmity and disease but also a state of complete physical,
mental, and social well being”, physicians were reminded that a patient’s health
was more than just a corporeal state, and could be affected by environmental and
social factors.
The subsequent appraisal of social and environmental factors, however,
was prompted not by medical researchers, but by major changes in government
activities. A National Health Survey[61], created in 1957, was intended to
measure the quality of health of the American people, not just longevity, and to
determine "the positive elements of good health rather than merely the absence
of disease and infirmity." To provide information for government officials and
public health experts, the survey was designed to examine the social aspects of
health, the personal impact of illness, the steps taken to prevent illness, and the
relation of medical care to other demographic variables.
In 1960, the President's Commission on National Goals—comprising
academicians, public servants, and leaders of industry—reported on the state of
the nation[62] and proposed an outline of national policies and goals for
improvement. Since only 48 of the stipulated 82 goals were measurable at that
time[63], a new set of measures was needed. During President Johnson’s
administration (1963-1969), public agencies were urged and supported to
develop more quantifiable new measurements to evaluate domestic social
programs and to stimulate change in those deemed ineffective [64].

Development of Social Indicators
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At about this time, the Social Indicators movement, led by psychologists
and sociologists, began[65] to advocate “monitoring change in such areas of
public life as education, health, employment, crime victimization, political
participation, and population growth and measurement”. These ideas were first
broadly disseminated in 1966 in a collection of essays[63] that referred to
measuring various aspects of society and comparing them with goals of the
nation. One of the essayists[66] complained that the widely available economic
data, usually reported through government agencies, could not be used to
analyze social systems.
When the Department of Health, Education, and Welfare published
Toward a Social Report[67] three years later, the authors advocated a change in
focus: "We have measures of death and illness, but no measures of physical vigor
or mental health. We have measures of the level and distribution of income, but
no measures of the satisfaction that income brings." The staff director of the
study later[68] lamented not only the emphasis on objective measurements, but
also the paucity of available non-income statistics. (Income statistics were
probably a main focus of social indicators because economists were the main
source of the measures).
A 1972 bibliography[69], showed that more than half of the more than
1000 articles related to Social Indicators had been published between 1970-72. In
1974, a new journal, Social Indicators Research, dedicated to scholarship and
research on the “quality of life,” began to include articles on pertinent
philosophical concepts, design and testing of new instruments, and studies using
those instruments.
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Subjective Measures of Well-Being
The 1976 publications of Campbell, Converse, and Rogers[70] and
Andrews and Withey[71] were highly influential in expanding the scope of social
science measurements. Although most previous data had referred almost
exclusively to objective phenomena, the new studies showed that subjective
indicators could be measured, thus enabling examination of the “soft data” for
“quality of life”. The ideas were based on the work of Cantril's self-anchoring
scale[72], Bradburn’s Scale of Affect Balance[73], and Campbell and Converse’s
earlier The Human Meaning of Social Change [74].
To Hadley Cantril[72], well-being was conceived as satisfaction with life,
and regarded as a cognitive process in which a person’s perceptions of life were
compared with his aspirations—the difference between the two being regarded
as his perceived well-being. In persons from 13 different nations, Cantril found
that the greatest well-being and satisfaction with life occurred when perceptions
of life were closest to aspirations.
Norman Bradburn[73], using the affective aspects of experience, viewed
subjective well-being as the balance between positive and negative affects. The
greater the ratio of positive affect to negative affect, the higher the sense of wellbeing. Bradburn’s scale used ten questions that each began with “During the
past few weeks did you ever feel...” and were answered with “often,”
“sometimes,” or “never.” Five questions aimed at positive affect (e.g., being
particularly excited or interested in something), and five at negative affect (e.g.,
being very lonely or remote from other people). Bradburn’s scale has
subsequently been used extensively, particularly in a 1981 national study of
33,000 Canadians[75].
In The Human Meaning of Social Change[74]—which dealt with issues
surrounding measurement of “aspirations, expectations, and satisfactions”—
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Campbell and Converse in 1972 laid the theoretical groundwork for later
publications. Their work was extended in 1976 in The Quality of American
Life[70], using data from 1971-1972 interviews on which a representative sample
of U.S. citizens described their lives. The investigators asked four separate types
of questions: a global question about life satisfaction; ten life characterizations
expressed in terms such as enjoyable/miserable and rewarding/disappointing;
more directed questions regarding satisfaction in such domains as employment
and housing; and further specifications of satisfaction within those domains. The
responses were then combined in various ways to yield the Overall Scale of Life
Satisfaction, Index of Well-being, Index of General Affect, and Index of Perceived Stress.
Using some of Campbell, Converse and Rodgers’s theoretical
arguments[70], Andrews and Withey[71,76] began to develop measures of life
quality for interviews conducted in 1972. The conceptual model also included
affective components of people’s lives, rather than just their physical or social
conditions. Respondents were asked questions such as, "How do you feel about
your life as a whole?" and “How do you feel about what you are accomplishing
in your life?” The 123 items in the questionnaire were grouped into 12 common
“life domains,” which were then assumed to represent quality of life.

Medicine and the Social Sciences
Early Clinical Attention to Quality of Survival and Life
Although the clinical measurements of functional status were often used
for elderly people, little or no attention was given by clinicians and researchers to
the early publications in the non-clinical literature of surveys that had been done
by psychologists using indexes to appraise happiness and psychological wellbeing[77,78]. One study[77], in 1953, used objective measures: good health,
financial security, hobbies and interests, friends, living with one's spouse, age,
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and sex. Another study[78], in 1961, used subjective measures, expressed as a
life satisfaction scale and two smaller life satisfaction indexes.
In what seems to be the first measure of the quality of survival in a clinical
trial, breast cancer patients in 1966 were studied after radical mastectomy or
limited surgery[79]. The post-operative questionnaire contained objective
measures such as lymphedema and activity status, but also an evaluation of the
patient's attitude. Activity status was determined from the patient’s ability to
return to the same level as before the operation. Attitude—rated as “good,”
“fair,” or “poor”—was based on the patient’s number of complaints. Although
the authors did not clearly state how the results of the questionnaire were
translated into the measures of attitude, this study seems to have been a
pioneering effort to include patients’ subjective opinions in comparing the effects
of treatment. In a 1968 report, functional status and attitude were replaced by a
battery of neurologic, psychiatric, and psychometric tests to denote quality of
survival after surgery for anterior cerebral artery aneurysms[80].
Despite these early advances, the standard approach for judging efficacy
of cancer therapeutic agents continued to be quantity of survival. After noting
that cancer patients were often distressed by the adverse (but unmeasured)
symptomatic effects of radiotherapy and chemotherapy, Feinstein et al.[81] in
1969 called for better methods that would measure quality of survival, at least
according to a patient’s pain, distress, or suffering. In studies during 1968-1983,
however, general symptoms[82,83] were appraised in only two reports, and
quality of survival continued to be assessed from functional status[84-90] or
attitude toward life[91,92].
As a specific concept, the term “quality of life” (rather than quality of
survival) seems to have entered the medical literature in a 1966 article[93] about
medically-indigent patients receiving hemodialysis. After noting that the post-
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dialysis medical problems included sepsis and cannula clotting, the authors
concluded that, “while an effective degree of life prolongation was obtained for
some of these patients, for most the quality of life was unacceptable” (italics
added). Quality of life seems to have been judged from such events as
difficulties finding a job, becoming too weak to care for children, and withdrawal
from spouse and children. The authors also acknowledged that the problems,
which had made all the patients contemplate suicide, might have been improved
with more suitable attention.
In a subsequent editorial, “Medicine and the Quality of Life”[94], J.R.
Elkinton borrowed Francis Bacon’s definition that quality of life is “the harmony
within a man, and between a man and world.” In view of all the technical and
ethical problems at that time, Elkinton questioned whether chronic dialysis
provided an acceptable quality of life, and called for physicians to participate
more actively in helping to make these decisions for society and for individual
patients.

Early Quality-of-Life Indexes and Social Science Transfers
The medical literature contained no instruments specifically aimed at
measuring quality of life until two appeared in 1970: the Vitagram Index[95] and
Life Units[96]. The Vitagram Index[95] was a two-dimensional graph with
duration of life on the X-axis. Quality of life, on the Y-axis, was determined from
a functional status scale that gave patients points for their ability to work and
ambulate. The area under the curve, regarded as the total quality of survival,
was assessed for patients who were receiving one of several treatments for lung
cancer.
Similar in design, Life Units[96] were constructed as a sum of the products
of years of life and “quality of life”, as determined by “social usefulness,”
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defined by restrictions on a patient’s ability to work. In this index, which was
designed for heart-valve transplant patients, the greater the number of life units,
the greater the success of the surgery. Although intended both to determine
efficacy and to aid decisions about whether a patient should undergo surgery,
this index seems never to have been mentioned again after its first report.
The first quality of life measurement to become popular was Priestman
and Baum’s 1976 Linear Analogue Self Assessment Scale[97], which used a visual
analogue appraisal[98-100]. On a ten-centimeter line labeled with extreme
“anchors” at each end, subjects placed a mark, corresponding to their feelings at
the moment. The ten questions in the index ranged from feelings of well-being,
to pain, to the patient’s perception of efficacy of treatment. The sum of the marks
given as ratings for the ten questions became an overall measure of quality of
life.
During the next few years, instead of continuing either this technique or
the early approaches based on health status, many investigators began to
appraise quality of life with instruments or components taken directly from the
social sciences. In 1982 Johnson et al.[101] used seven variables and the Affect
Transformation Scale from previous social science publications[70,73]. The
research showed that patients with successful transplants had a better quality of
life than hemodialysis patients for whom transplantation was not planned,
awaited, or already failed. Appraising the quality of life results, the authors
urged “continued efforts to apply social psychological research to clinical
investigations…for evaluating medical interventions of many different kinds.”
In 1984, Simmons et al.[102], also appraising quality of life in patients
receiving hemodialysis, used a theoretical framework that combined physical,
social, and emotional well-being, including the previously developed Index of
Well-Being[70]. The latter index as well as the Index of Psychological Affect and
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Index of Overall Life Satisfaction —all scales previously developed by Campbell,
Converse, and Rodgers[70]—were used by a nephrology group, led by R.W.
Evans, to measure quality of life in a study comparing patients receiving
transplanted kidneys from living versus cadaver donors[103] and in another
study of patients with end-stage renal disease[104]. The authors said they chose
the three cited indexes because comparative data were available from a set of
normal populational controls. In a 1983 analysis of outcomes after heart-valve
surgery[105], the investigators used multiple instruments, but the subjective
section of one of the questionnaires included Bradburn’s Scale for Well-being[73].
From the social sciences, physicians also borrowed psychological tests as
part of a battery of appraisals. Examples of such usages before 1984 include the
following indexes: Rorschach test[106], Shanan Sentence Completion Technique[106],
Psychosocial Adjustment to Illness Scale[107], Mooney Problem Checklist[108],
Minnesota Multiphasic Personality Inventory[107], and Profile of Mood States[108,
109]. Other borrowed approaches included the use of sociologic guidelines for
questionnaires[110,111] and (in health services research) economic forms of
utility analysis[112,113].

New Incentives for Quality-of-Life Measurement
In 1985-86, two major events added substantial impetus for measuring of
quality of life in clinical trials.
One of these events was the Food and Drug Administration’s (FDA)
decision to require quality of life data as one of the “key efficacy parameters” in
clinical trials for new anticancer agents[114]. The FDA said it would be willing to
approve a drug in certain cases if it only reduced pain or toxic effects. A working
group from the FDA and the National Cancer Institute[115] later recommended
that validated quality of life instruments be used for comparing either pre- and

Page 16
post-treatment, or treatment versus placebo groups. The stated belief was,
“[R]easonable assurance that a new drug imparts comparable net patient benefit
is a legitimate basis for demonstrating effectiveness.” In the original statement,
the FDA defined quality of life only in relation to performance status or pain, but
the later recommendation allowed measurement of improvement in tumorcaused symptoms, in functional status, in body mass, and in psychological
status, as well as decreased reliance on medical support.
The second influential event occurred when quality-of-life assessment was
used as the primary outcome in a randomized trial published prominently in the
New England Journal of Medicine in 1986, with widespread publicity thereafter. To
examine the quality of life for patients taking one of three anti-hypertensive
medications, Croog et al.[116], checked satisfaction with life, physical state,
emotional state, intellectual state, social functioning, and the Index of WellBeing[70]. When the results showed superiority for one of the anti-hypertensive
agents, pharmaceutical manufacturers realized that their products could be
promoted not just for physiologic effects, but for quality of life.
With these regulatory and commercial incentives, clinical investigators
and their statistical consultants began to augment their customary data with
methods of measuring quality of life, and began to rely on the “accepted”
approaches offered by either the “established” health status or psychosocial
indexes. A search for “quality of life” as a Medline subject heading for each year
from 1969 to 2000 produced the results shown in Figure 1. A relatively small but
steady rise in articles occurred during 1975-1988, but a sharp increase began in
1989 and has continued thereafter.
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Figure 1. Number of articles with "Quality of Life" as a Medline subject heading,
1969-2000.

This review of the entrance and early evolution of quality of life
measurements in medicine will end here, because the subsequent developments
and current status of those measurements have been abundantly described
elsewhere[1,3,8,17,117-119]. The field has now grown so extensively that it is
regularly discussed at symposia and large meetings; and it is the sole focus of an
international journal, Quality of Life Research.
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Discussion
The current review demonstrates that the concept and measurement of
“quality of life” entered medical research from two different sources, each of
which led to different problems. Indexes of functional capacity and
performance, originally developed for evaluating treatment of patients, were
later augmented by appraisals of social, emotional, and other functions to
produce indexes of health status. The health-status indexes, although often
adequate for assessing health status, were then used inappropriately to denote
the quality of life for individual persons.
Indexes of happiness, well-being, and other “affects” had been developed
by social scientists to assess populational phenomena and had been constructed
with sociometric or psychometric principles of measurement. The populational
results were not always suitable, however, for individual patients, whose most
pertinent quality-of-life components might not have been included or suitably
weighted among the multiple items of the populational instrument. A separate
problem was that a person’s “quality of life” might be influenced much more by
non-medical than by medical phenomena. Furthermore, the multi-item
populational instruments were not always effective in assessing the changes that
occurred after therapeutic interventions.
The current instruments, while useful for measuring functional status,
happiness, or other “affects,” have been misused by researchers who claim that
they represent the “quality of life” of individual patients. This and other
problems in the current assessment of quality of life as well as suggestions for
better measurements are considered in the discussion that follows.
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Reasons for Plethora of Instruments
An outsider observing the current scene might readily ask why the
literature contains so many quality-of-life indexes for such a diverse array of
diseases.
One immediate reason is the distinction between “quality of life” and
“health-related quality of life.” To avoid including non-medical components—
such as family problems, economic status, and religious or spiritual influences—
investigators later decided to focus on medical factors, expressed as a
combination of functional status and symptoms related to specific diseases.
Whether this combination adequately reflects “health-related quality of life” is an
arguable issue, but the many different symptoms of different diseases would
obviously lead to a diversity of indexes for “health-related quality of life”.
Another reason for the plethora of indexes may be that investigators do
not always complete a thorough search of the literature to see if an adequate
index already exists for their study. A statement by Lawton and Brody[34] more
than 30 years ago is often still applicable today: “The present state of the trade
seems to be one in which each investigator or practitioner feels an inner
compusion [sic] to make his own scale and to cry that other existent scales cannot
possibly fit his own setting.”
Perhaps the most cogent reason for the many indexes, however, may be
that the clinical outcomes most desired by patients receiving treatment are relief
of symptoms, improvement in function, and avoidance of adverse reactions.
These attributes, though, are often transferred to a different concept, called
“quality of life”, which is difficult to measure because a person’s quality of life –
even when solely “health-related” – has different components, significance, and
meaning that are unique for each person.
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Patient-centered versus Group-centered Indexes
Since physicians and family relatives may often misconstrue patients’
beliefs about quality of life[105,120-121], investigators have included different
categories of people when constructing an index. This approach is well
illustrated with the QL-Index[122], which was developed from surveys of more
than 1000 people in Australia, who were asked what they regarded as quality of
life and what domains should be included in a brief, simple scale. The
respondents comprised cancer patients, their relatives, patients with other
chronic diseases, relatives of those patients, healthy people aged ≥ 20, doctors,
nurses, social workers, and clergy who were seen in various settings that
included the clinic, the hospital, and a terminal-care hospice. Despite admirable
size and efforts in the survey, the result—a summary and consensus of the 1000
participants—may not allow adequate expression for the way that individual
patients determine their own quality of life. A pain that is tolerated by one
patient might be unbearable to another. The inability to return to work might
devastate a thirty-year old but hardly affect a seventy-year old. These individual
differences are not easily cited in populational-consensus quality-of-life indexes.
In multi-item questionnaires, each question may be given an equal weight
or weights determined either from a group consensus or a mathematical model.
If patients, however, are not invited and allowed to state their own beliefs and
the relative importance of those beliefs, the result is a quality-of-life assessment
produced by investigators, physicians, consensus, or mathematical formulas, not
by the pertinent individual patient.

Single Global Rating versus Multi-item Questionnaires
A patient’s single simple global rating (such as a visual analog mark,
verbal category, or numerical score) for gradations such as poor or good can
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eliminate the inadequacy and bias inherent in letting researchers choose and
weight a set of individual domains. After patients give this simple rating for
how they feel about the relative excellence of their own quality of life, a separate
second rating can be given for “health-related quality of life,” either directly or
for the impact of health on the previous rating. If desired, the particular entities
that most affect the favorable or unfavorable ratings can be discerned from the
patient’s further responses either to more open-ended questions or to a suitably
organized checklist of possibilities.
The purpose of the results would be to provide a direct, appropriate
assessment of quality of life. The new ratings would be a supplement, not a
replacement, for separate pertinent indexes that appraise associated phenomena,
such as changes in symptoms, functional capacity, and other components of
health status.
The simple two-question approach to “quality of life” seems clinically
sensible and offers unquestionable “face validity,” but more study is needed to
determine the optimal method of carrying out this type of patient-centered
inquiry. Among the issues to be addressed are the method of phrasing questions
to be sure the patient understands what is being asked and the choice of the best
type of rating scale (graphical, categorical, numerical) for the single global
expressions.
The phrasing of questions is an important issue because differences in
patients’ cultural and educational backgrounds may lead to different beliefs
about what is meant by “quality of life.” Although ratings can be offered in the
graphic form of a visual analog scale, or in verbal or numerical categories, the
comparative efficacy of these formats has not been studied for quality-of-life
measurements[123]. A best format did not emerge from an investigation of
rating scales for pain[124].
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For investigators who use patient-centered multi-item indexes, the most
effective structures have also not been clearly demonstrated[125-130]. Among
the issues to be resolved are the optimal number of questions to be asked, and
whether patients, when asked again at later times, will change the items that they
originally emphasized. To shorten the time for completing responses, various
studies have constrained patients to including only five components for quality
of life[126-129]. Since some patients may have more and others fewer than five
important components, another uncertain issue is the optimal balance between a
patient’s choice of the quantity of components and the amount of time required
to complete the questionnaire.
Most multi-item questions have referred only to the magnitude of a
particular component, such as a disability, but not its importance. A few recent
indexes[128-130] have solicited ratings of both magnitude and importance for
each item, but an optimal method has not yet been developed for analyzing the
concomitant pair of ratings.
Finally, any multi-item instrument for quality of life should contain
optional sections marked “other,” in which patients can note personally
important components that were not included in the cited list of items.

Challenges in Measuring Change
A separate set of challenges arises when quality of life is measured
repeatedly to appraise changes after therapy or other clinical interventions. If the
same index is used each time, patients may not recall their prior ratings for each
item; and their subsequent responses may not accurately represent what
happened. One approach to this problem—letting the patients see their previous
ratings before making new ones—is sometimes avoided because of fear that the
new rating may be biased over the old one.
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An alternative approach is to avoid using the original scale of ratings and,
instead, to use a transition scale[131] which contains a set of comparative
categories such as much better, better, same, worse, and much worse. Transition
scales have the advantage that ratings of change can be given without reference
to previous values. The main disadvantage is the need to be sure that patients
understand the reference basis for each change, i.e., does it refer to the
immediately previous state or to the original state, before treatment? (This
problem does not arise with a simple two-state before-and-after transition). A
separate disadvantage, which is clinically trivial but sometimes important
mathematically, is that transition ratings do not permit use of the repeatedmeasures analysis-of-variance model, which is often favored by certain
statisticians.
Finally, a different problem in multi-item instruments is the issue of
responsiveness, i.e., the ability to show change. As noted by Nunally[132], the
diverse up-and-down changes in multiple items can not be easily or clearly
aggregated into a clear decision about change. This difficulty is an important
reason for favoring the use of a single global index for expressing quality of life,
and then a simple transition scale for citing change.

Conclusion
The current problems and imperfections in quality-of-life indexes can be
attributed to, and explained by, an origin in two different streams of thought,
neither of which has led to a fully satisfactory approach. From the medical
stream, the transfer of health status indexes was not a suitable way to denote a
patient’s belief about quality of life. From the psychosocial stream, the multiitem instruments, based on consensus or other populational decisions, may not
allow patients to express and weight the diverse features that can affect their
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own feelings, and to adequately report changes in status. Since quality of life is
determined uniquely by each patient, and reflects a personal reaction rather than
an objective “status”, a possible solution to the problems is to return to an old
clinical approach, which directly asks patients to indicate what they feel.
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